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Abstract
Objectives: Carbon tetrachloride (CCl4) is one of the
most dangerous hepatotoxic environmental pollutants
thus this study aimed at investigating the potential pre-
ventive effect and mechanism of crocin against CCl4-
induced hepatotoxicity.
Methods: Forty Male rats were allocated for two weeks
treatment with; corn oil, CCl4 in corn oil, crocin (100 mg/
kg), or crocin plus CCl4. At time of euthanasia liver was
removed, weighted and processed for histopathological
evaluation and estimation of liver contents of active
caspase3, lipid peroxidation (MDA) and reduced gluta-
thione (GSH). We also evaluated antioxidant enzymes
activities [superoxide dismutase (SOD), glutathione
peroxidase (GSH-Px) and catalase (CAT)], phase I
metabolizing enzyme [cytochrome P450 sub family 2E1
(CYP2E1)] an Phase II metabolizing enzyme,
[glutathione-S-transferase (GST)] in liver tissue. Blood
samples were used for evaluation of liver function tests
and inflammatory cytokines [interleukin 6 (IL-6) and
tumor necrosis factor alpha (TNF-a)].y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2014.09.003
S. Bahashwan et al. 141Results: CCl4 induced significant (p < 0.001), increase in:
relative liver weight to body weight, liver MDA content,
liver active caspase-3 and plasma levels of IL-6 and TNF-
a. In addition, CCl4 disturbed liver histology, liver
metabolizing enzymes (CYP2E1 and GST), and liver
function tests (aspartate aminotransferase, alanine
aminotransferase, total bilirubin and alkaline phospha-
tase). CCl4 induced significant decrease in activities of
SOD, CAT, GSH-Px and GSH content. Administration
of crocin with CCl4 mitigated all CCl4-disturbed pa-
rameters and preserved liver histology close to normal.
Conclusion: Crocin ameliorated CCl4-induced liver
injury via inhibition of inflammatory cytokines, caspase3
and oxidative stress along with modulation of liver
metabolizing enzymes favoring elimination of CCl4 toxic
metabolite.
Keywords: Carbon tetrachloride; Liver toxicity; Oxidative
stress; Crocin
 2014 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Carbon tetrachloride (CCl4) is a common industrial sol-
vent which is well known for its hepatotoxicity.1e3 CC4 is
used in the synthesis of chlorinated organic compounds
including chlorofluorocarbon refrigerants, agricultural
fumigant, in the production of semiconductors, in the
processing of fats, oils and rubber and in laboratory
applications.4,5
Occupational exposure to carbon tetrachloride may occur
in the chemical industry, in laboratories, and during
degreasing operations.6,7 Numerous poisonings and fatalities
have occurred due to high exposure to carbon tetrachloride.
The major pathological changes have been seen in the liver
even at levels that were generally below 5 ppm (32 mg/
m3).8,9 Liver damage can occur after 24 h and in serious
cases resulted in hepatic coma and death.10,11 Through the
investigation of acute CCl4-induced liver damage in animal
models, it is now generally accepted that CCl4 toxicity
resulted from free radical generation by cytochrome P450
system in liver microsomes and consequently causes lipid
peroxidation of membranes that leads to liver injury.12e15
One of the possible popular successful approaches for the
protectionandeven treatmentof liverdamagedue tooxidative
stresscouldbeachievedthroughuseofphytochemicalswithanti-
oxidant properties.13,16,17 One such phytochemical is crocin, a
main constituent of the Crocus sativus (Saffron), exhibits a
variety of pharmacological effects including inhibition of skin
tumor growth in mice,18 improvement of learning behavior
previously impaired by ethanol,19 anti-hyperlipidemic ef-
fects,20anti-atheroscleroticeffects,21andanti-cancereffect.22,23
Interestingly, recent studies indicated, potential free radicalscavenging, antioxidant and lipid peroxidation inhibition
propertiesofcrocin.24,25
Note worthily, study by Lin and Wang26 pointed out a
first clue for partial hepatoprotective effect of crocin
against liver carcinogenesis induced by diethylnitrosamin
and aflatoxin B1. Our previous study documented a
possible protective utility of crocin against brelyium
chloride-induced brain and liver injury.25 As a continuation
for efforts to establish an effective hepatoprotective
modality utilizing nature substance against CCl4 an
environmental toxin, it is a pertinent to study crocin in
well-designed animal model for liver toxicity, which will
answer questions regarding its protective utility and poten-
tial mechanism. Therefore, the global aim of this proposal is
to evaluate the potential protective utility of crocin against
hepatic toxicity induced by carbon tetrachloride. Moreover,
exploring the possible mechanisms whereby this agent
mediated its beneficial effects.
Materials and Methods
Animals and study protocol
Forty male SpragueeDawley rats (200e250 g) were kept
at 20e25c in a 12 h light/12 h dark cycle with free access to
food and water. The animals were feed standard chow and
water ad libitum. The experimental protocols were approved
and carried out according to guidelines for the use and care
of experimental animals.
Design of the work
After a period of adaption, rates were classified into four
groups (n ¼ 10) as follow:
➢ Group I: Negative control; treated intraperitoneal (i.p.)
with corn oil in a dose of 0.2 ml/100 g animal.
➢ Group II: crocin group; injected i.p. with crocin in a dose
of 100 mg/kg/day.25,26
➢ Group III: CCl4 group; Injected i.p. with CCl4, dissolved
1:1 in sterile corn oil. In a dose of 0.2 mL/100 g animal for
two consecutive days/week.13,28,29
➢ Group IV: Combination group; injected I.P with both
crocin and CCl4 using the same doses schedule mention
before.
Animal treatment was continued for 2 weeks then the
experiment was concluded and animals were killed under
anesthesia, blood samples were collected and livers were
rapidly removed then weighted to calculate relative liver
weight to body weight. Liver and blood samples were pro-
cessed for measuring the following parameters:
Biochemical analysis:
Each blood sample were placed in dry clean centrifuge
tube, and then centrifuged for 10 min at 3000 revolutions per
minute (rpm) to separate the serum. Serum was carefully
separated into clean dry Wassermann tubes by using a Pas-
teur pipette and used for determination of serum liver
function tests [(aspartate aminotransferase (AST), alanine
aminotransferase (ALT) alkaline phosphatase (ALP) and
total bilirubin,] using standard techniques.30
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Liver samples were fixed in 4% buffered formaldehyde,
embedded in paraffin, and stained with hematoxylin-eosin
according to Bancroft and Stevens.31 Histologic evaluation
was performed twice by two pathologists blinded to the
protocol.Estimation of liver metabolizing enzymes activities
Cytosol and microsomes fractions were prepared at 0e
4 C from liver tissue homogenate according to method of
Benson et al.,32 and used for evaluation of metabolizing
enzymes. Liver microsomal phase I metabolizing enzyme;
CYP2E1 activity was assayed using p-nitrophenol as a
substrate33 Cytosolic liver phase II metabolizing enzyme;
Glutathione eS-transferase (GST) activity was determined
using 1-chloro 2,4 dinitrobenzene (CDNB) as a substrate
according to method of Habig et al.34 GST and CYP2E1
activities were normalized against protein content and
presented as percentage of corresponding control values.Measurement of liver oxidative stress status
Liver tissue malondialdehyde (MDA), an indicator of
lipid peroxidations; superoxide dismutase (SOD); catalase
(CAT); glutathione peroxidase (GSH-Px); and reduced
glutathione (GSH) measurements were performed as
described previously35e38 to determine the oxidative status in
the liver specimens.Evaluation of inflammatory cytokines
Plasma Interleukin-6 (IL-6) was determined colorimetri-
cally using rat Elisa Kit (IBL Co., Ltd. Hamburg, Germany)
in accordance with the manufacturer’s instructions. Plasma
tumor necrosis factor alpha (TNF-a) level was determined
via a commercial ELISA kit (IBL Co., Ltd. Hamburg,
Germany) using standard curve according to supplier
protocol.Table 1: Effects of crocin on body and liver weights of carbon
tetrachloride (CCL4) treated rats at the end of study (2 weeks).
Body weight
(% of initial)
Liver weight/100 g
body weight
Control 116.64  3.7* 4.5  0.10
Crocin 113.5  4* 4.4  0.20
CCL4 94.17  2.6a,b,* 5.8  0.25a,b
Combination 100.47  3.2a,b 4.7  0.17cEvaluation of active Caspase3
The caspase-3 enzyme activity was measured in liver tis-
sues collected from rats in the four treatment groups using
the CaspACE assay system (Promega Corp., Madison, WI)
based on the ability of the caspase 3 enzyme to release the
yellow chromophore p-nitroaniline (pNA) from the colori-
metric substrate (Ac-DEVD-pNA) provided in the
CaspACE assay system. Relative caspase-3 activities for each
sample and sample plus inhibitor were calculated from the
standard curve as described previously.39 Caspase-3 activity
values were normalized against sample protein content and
presented as percentage of control value.  Data were calculated as relative weight of liver to 100 g animal
body weight at the end of experiment.
 Data are presented as mean  standard error of 10 animals/
group.
 a, b or *, c indicates significant difference from control, crocin or
corresponding initial body weight respectively at p  0.01 using
Tukey’s test as post ANOVA test.Statistical analysis
Results were expressed as mean SE, and the significance
of differences were assessed by one-way ANOVA and
Tukey’s test as post hoc. The differences were accepted as
statistically significant when P value was less than 0.05.Results
Effect of treatment on body weight and relative liver weight
to body weight
As illustrated in Table 1; the ratio of liver weight to 100 g
body weight was significantly increased by sole
administration of CCl4 (5.8  0.25, p < 0.01) compared to
control animals showing 4.5  0.10. Interestingly treatment
with both crocin and CCl4 exhibited liver weight/100 g
body weight ratio of 4.7  0.17 which is significantly lower
than CCl4 group (p < 0.01) and was close to normal value
(Table 1). Comparing the animal total body weight at the
end of experiment to its corresponding initial value, only,
CCl4 group exhibited a significant decrease compared to its
corresponding initial weight (Table 1). Note northerly, the
body weights exhibited by combination group had higher
values compared to both it initial body weight and body
weights exhibited by CCl4-treated group however it is still
less than the control values (Table 1).
Histological findings
Liver sections of control rats showed normal cellular ar-
chitecture with distinct hepatic cells, sinusoidal spaces and
central vein (Figure 1). Liver sections obtained from CCl4
treated rat showed disarrangement of normal hepatic cells,
pale stained hepatocytes around the central vein (C) with
extensive vacuolization around the central vein massive fatty
degeneration, multifocal centrilobular hepatic cell death, and
cellular infiltration, and massive numbers of inflammatory
cells infiltration (Figure 1). Conversely, mild vascular
congestion (V) was detected in the crocin sections with no
histopathological alteration appearing in hepatocytes.
Compared to CCl4 group, interestingly, livers of rats treated
with crocin and CCl4 revealed better preservation of the
normal liver architecture and rare generalized vacuolization
of the cytoplasm of hepatocytes, with apparently normal
nuclei, very few inflammatory cells infiltration (Figure 1).
Effect of treatment on liver function tests
The serum levels of liver functions (ALP, ALT, AST and
total bilirubin) are presented in Table 2. In the CCl4 treated
Figure 1: Representative H&E micrographs from liver tissues collected from rats treated with; corn oil (control), crocin, carbon tetra-
chloride (CCl4), and combination of crocin and CCl4. Control section showing normal histological structure of the central vein(c) and
surrounding hepatocytes (h). CCl4 treatment for two weeks showed pale stained hepatocytes around the central vein (C) with cytoplasmic
vacuolization. CCl4 induced histological changes manifested by massive number of inflammatory cells infiltration, fatty change, degen-
eration, necrosis and apoptosis in most of the hepatic parenchyma. Conversely, crocin treatment had no significant histopathological
alteration except mild vascular congestion (V) while treatment with crocin plus CCl4 restored normal liver histology, although showing
slight inflammatory cells infiltration, few fatty changes and moderate generalized vacuolization of the cytoplasm of hepatocytes, with
apparently normal nuclei, compared to CCl4 alone.
S. Bahashwan et al. 143group, the serum levels of ALP, ALT, AST and total
bilirubin significantly, p < 0.01, increased to 369  8.5,
390  6.9, 461  11.3 and 2.5  0.007 respectively,
compared to negative control group values of 66  2.7,
42  3.9, 36  3.2 and 0.28  0.005 respectively.
Pretreatment of CCl4-treated rats with crocin significantly,
p < 0.01, decreased the CCl4 induced elevation of these
markers levels to 160  7.4, 183  9.6, 138  8.5 and0.5  0.009 respectively (Table 2). Interestingly, sole crocin
administration does not exhibit any significant change from
control values of liver functions.
Effect of treatment on metabolizing enzymes in liver tissue
The effects of crocin and/or CCl4 on activities of phase I
metabolizing enzyme; (CYP2E1) and Phase II metabolizing
Table 2: Effect of crocin and or carbon tetrachloride on liver function test in rats after two weeks of treatment.
Control Crocin CCL4 Combination
ALP (U/L) 66  2.7 82  3.8 369  8.5a,b 160  7.4a,b,c
ALT (U/L) 42  3.9 44  2.75 390  6.9a,b 183  9.6a,b,c
AST (U/L) 36  3.2 38  1.3 461  11.3a,b 138  8.5a,b,c
Total bilirubin (mg/dL) 0.28  0.005 0.29  0.004 2.5  0.007a,b 0.5  0.009a,b,c
 Data were presented as mean  standard error of 10 animals/group.
 a, b or c indicates significant difference from control, crocin or CCl4 respectively at p  0.01 using Tukey’s test as post ANOVA test.
 ALP: Alkaline phosphatase; AST: Aspartylaminotransferase; ALT: Alanine aminotransferase.
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Figure 2: Effect of crocin and or carbon tetrachloride (CCl4) on
liver metabolizing enzymes activities in rat after two weeks of
treatment.
 Enzymes are calculated as nmol of substrate/min/mg protein (normalized against
tissue protein content) and presented as percentage of control value.
 Data are presented as mean  standard error of 10 animals/group.
 a, b or c indicates significant difference from control, crocin or CCl4, respectively, at
p  0.01 using Tukey’s test as post ANOVA test.
 CYP 2 E1: cytochrom P450 subfamily 2 E1; GST: glutathione eS- transferase.
Crocin protects liver against carbon tetrachloride144enzymes (GST) are compiled in Figure 2. Administration of
CCl4 resulted in a significant, p < 0.01, increase in CYP2E1
activity to 260%  6.8 of control value with concomitant
significant decrease in GST activity to 45%  2.2 of
control value respectively, p < 0.01. Conversely sole
treatment with crocin exhibited an opposite effect. Crocin
treated rate exhibited 60%  1.7 and 210%  8.1 of
control values for CYP2E1, and GST respectively.
Interestingly, addition of crocin to CCl4 treatment
abrogated CCl4-induced disturbance of metabolizing en-
zymes and normalized all values.
Effect on lipid peroxidation and GSH level in liver tissue
CCl4 caused a substantial increase in liver MDA content
to 19.3  0.5 with concomitant significant fall in liver GSH
content 76  2.2 compared to control group (Table 3).
Administration of crocin alone showed a non-significant
decrease in liver MDA content, 4.5  0.5 (Table 3), while
exhibited a significant increase in GSH content 168  3.3
compared to control group (Table 3). Combined
administration of crocin and CCl4 resulted in a significant
reduction in the liver MDA content (8.4  0.75) with
significant increase in liver GSH content (120  4.4)
compared to CCl4 treated group (Table 3).
Effect of treatment on antioxidant enzymes activities in liver
tissue
Table 3 shows the activities of enzymatic antioxidants
(CAT, SOD, and GSH-Px) in the rats liver tissue. A signifi-
cant decrease, p < 0.01, in the activities of the above
mentioned enzymatic antioxidants activities was observed
after CCl4 administration (18  1.3, 190  12 and 8.25  0.7
respectively) compared to control values of 32  3.2,
380  10 and 15.34  0.3 respectively. In contrast, crocin
alone treated group showed a significant increase in liver
CAT, SOD and GSH-PX activities compared to control
values. However, concomitant administration of crocin with
CCl4 significantly restored these enzyme activities back to-
wards normalcy (27  2.2, 360  9 and 13.32  0.9 for CAT,
SOD and GSH-Px respectively) as shown in Table 3.
Results of plasma interleukin-6 and plasma tumor necrosis
factor alpha
Table 4 showed that there was significant increase in
plasma levels of IL-6 (110  6.3) and TNF-a (188  6.6) in
Table 3: Antioxidant enzymes activities, reduced glutathione content and lipid peroxidation content in liver tissue of rats treated with
crocin and or carbon tetrachloride (CCL4).
CAT
(U/mg protein)
SOD
(U/mg protein)
GSH-PX
(U/mg protein)
GSH
(umol/mg protein)
MDA
(nmol/mg protein)
Control 32  2.20 380  10 15.34  0.3 132  3.5 4.75  0.25
Crocin 39  1.20a 430  10a 18.39  0.5a 168  3.3a 4.5  0.50
CCl4 18  1.30a,b 190  12a,b 8.25  0.7a,b 76  2.2a,b 19.3  0.50a,b
Combination 27  2.25b,c 360  9b,c 13.32  0.9b,c 120  4.4b,c 8.4  0.75a,b,c
 Data are presented as mean and standard error of 10 animals each group.
 a, b or c indicate significant change from control, crocin or CCL4 using Tukey’s test as post ANOVA test at p < 0.01.
 Animals were treated for 2 weeks.
 CAT: Catalase; SOD: superoxide dismutase; GSH-PX: glutathione peroxidase; GSH: reduced glutathione; MDA: malondialdehyde.
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S. Bahashwan et al. 145CCl4 treated group as compared to normal control group
exhibited; 39.7  2.5 and 22  1.4 for IL-6 and TNF-a
respectively. On the contrary, crocin treated group had no
significant change from control values. Interestingly, animals
treated with both crocin and CCl4 exhibited significant
mitigation of CCl4-induced changes in IL-6 and TNF-a
(62  3.6 and 55  2.7 for IL-6 and TNF-a respectively).
Caspase-3 activity in liver tissue of rats treated with crocin
and or CCl4
The CCl4 treated group exhibited a significant (p < 0.01)
increase in active caspase-3 content to 416%  19.5 of con-
trol value in liver tissue (Figure 3). Sole crocin administration
had no significant effect on active caspase 3 activity
(98%  3.7 of corresponding control value). While animals
treated with crocin and CCl4 (combination group) showed
a significant (p < 0.01) suppression in caspase-3 content,
143%  5, compared to CCl4 treated group (Figure 3).
Discussion
This study aimed at evaluation of protective utility of
crocin, a natural compound consumed in human diet,
against CCl4-induced liver injury in rats. Since, it is well
established that, CCl4-induced liver toxicity is mediated in
part via free radical generation,40 crocin was chosen in ourTable 4: Effect of treatment with crocin and or CCL4 on
plasma inflammatory cytokines levels.
Control Crocin CCl4 Combination
Plasma
IL-6
(pg/ml)
39.7  2.5 42  2.5 110  6.3a,b 62  3.6a,b,c
Plasma
TNF-a
(pg/ml)
22  1.4 24  1.5 188  6.6a,b 55  2.7a,b,c
 Data are presented as mean and standard error of 10 animals
each group.
 a, b or c indicate significant change from control, crocin or CCL4
using Tukey’s test as post ANOVA test at p < 0.01.
 Animals were treated for 2 weeks.
 IL-6: interleukin 6; TNF-a; Tumor necrosis factor subfamily
alpha.study as a potential protective agent because of its
antioxidant activity.25
Per our results, CCl4 induced liver toxicity in rats which
was evidenced by: increased liver weight to body weight
elevated liver enzymes and total bilirubin, an indication of
structural and functional defects in liver cells,41,42 along with
histological disturbance of liver tissue. Our study indicated
that, CCl4-induced liver toxicity are possibly mediated
through: 1) generation of free radical and oxidative stress,
indicated by: a) abrogation of antioxidant enzymes activity
and glutathione content, b) elevation ofMDA in liver tissues,
2) induction of phase I metabolizing enzymes leading to more
production of CCl4-generated free radicals and concomitant
inhibition of phase II metabolizing enzymes leading accu-
mulation of CCl4-generated free radicals, 3) induction of
inflammation confirmed by: a) elevation of: IL-6 and TNF-a
and b) histopathological investigation, 4) activation of cas-
pase cascade of apoptosis indicated by the reported increaseCo
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Figure 3: Effect of carbon tetrachloride (CCl4), crocin or both
crocin and CCl4 on active caspase- 3 activity in rat liver tissue.
 Animals were treated for 2 weeks.
 Caspase-3 activity values were normalized against tissue protein content and pre-
sented as percentage of control value.
 Data are presented as mean and standard error of 10 animals each group.
 a, b or c indicate significant change from control, crocin or CCL4 using Tukey’s test
as post ANOVA test at p < 0.01.
Crocin protects liver against carbon tetrachloride146in activity of active caspase-3 leading to damage of liver cells.
These damaging effects could explain the elevated levels of
liver enzymes and disturbance of liver functions reported in
our results.13,42
Of particular interest, crocin effectively protected against
CCl4-induced hepatotoxicity in rats. These protections are
approved via: 1) restoration of relative liver weight to body
weight (Table 1), 2) normalization of liver enzymes and
serum total bilirubin (Table 2), 3) improvement of liver
histological pictures, (Figure 1). According to our study
these beneficial effects could be mediated through: 1)
inhibition of CCl4 induced disturbance of metabolizing
enzymes (Figure 2) leading to reduction of CCl4-induced
free radical generation, 2) inhibition of lipid peroxidation
manifested by decreased MDA content in liver (Table 3), 3)
induction of antioxidant enzymes activity and elevation of
reduced glutathione content (Table 3). Furthermore, 4)
crocin inhibited CCl4-induced inflammation indicated by
abrogation of CCl4-induced elevation of plasma IL-6 and
TNF-a levels (Table 4); 5) inhibition of caspase 3 activity, an
effect that protects liver cells from death (Figure 3)13,43 and
6) some or all of the above. These findings support our
earlier report pointed out the hepatoprotective effect of
crocin against brylium chloride-induced liver injury via
antioxidant activity.25
CYP2E1, a phase I metabolizing enzyme, catalyzes the
bioactivation of CCl4 to its highly reactive trichlomethyl
peroxyl radical (CCl3 OO) and superoxide anion free radi-
cals.13,44,45 These radicals initiate lipid peroxidation thereby
contributing majorly to the pathogenesis of liver toxicity.46e
48 In contrast to Phase I, Phase II metabolizing enzymes such
as GST is involved in detoxification of CCl4 and its reactive
metabolites to facilitate their elimination from human
body.46,49 Agents that induce Phase II enzymes have been
reported to protect against toxic effects of chemicals in
rats.50e52
Therefore, the toxicity of CCl4 depends, in part, on the
balance between the activities of phase I and phase II en-
zymes. Thus protection could be achieved in part by inhib-
iting metabolism of CCl4 and enhancing excretion of toxic
metabolites secondary to induction of phase II detoxifying
enzymes.53 This principle has been supported by previous
results.54e57
Coping with this principle, our study showed significant
induction of Phase I metabolizing enzyme (CYP2E1) and in-
hibition of Phase II metabolizing enzyme (GST) by CCl4
leading to oxidative stress, confirmed by induction MDA
content and abrogation of antioxidant enzymes and gluta-
thione content, and hence liver damage confirmed by H&E
staining and manifested by disturbed liver functions.46,47,58
Interestingly, treatment with crocin inhibited phase I and
stimulated phase II metabolizing enzymes which in turn
decreased the level of free radicals generation and abrogated
CCl-4 induced oxidative stress which would preserve the
integrity of liver cells and hence normalized liver histology,
relative liver weight to body weight and liver enzymes.
Furthermore, in addition to modulation of metabolizing
enzymes by crocin, the inhibition of CCl4-induced oxidative
stress by crocin in this study could be ascribed also to its
antioxidant characters via induction of enzymatic antioxi-
dant activities (SOD, CAT, GSH-PX) and non-enzymatic
antioxidant namely GSH which in turn abrogated the lipidperoxidation as evidenced by diminished MDA level
compared to CCl4-treated group.
Noteworthy to mention that, the amount of carbon tet-
rachloride metabolized in a given tissue is related to the
CYP450 content of the tissue.59,60 In the liver, the greatest
accumulation of carbon tetrachloride metabolites occurs in
the centrilobular region, which has high CYP450 levels.44,59
These fact could explain the major histological disturbance
in this region as illustrated in histological pictures.
Furthermore the metabolic rate of CCl4 in humans is more
similar to the rate in rats than in other rodent species.44
Tumor necrosis factor-alpha (TNF-a) and IL-6 are cen-
tral regulators of inflammation61 and have been increased in
many inflammatory conditions such as chemical toxicity.62
The anti-inflammatory effect of crocin has been studied
before where crocin showed a suppressive activities on
diverse proinflammatory mediators such as NO, IL-1b,
TNF-a, and reactive oxygen species.27,63,64 Our results are
in line with these reports where crocin suppressed CCl4-
induced elevation of 1L-6 and TNF-a, which could
contribute for the protective effect of crocin against CCl4-
induced liver damage.
The increased level of caspase 3 in liver tissue collected
from animal treated with CCl4 might be attributed to
oxidative stress and induction of inflammation.27,65 Caspase
3 plays the pivotal role in apoptosis where it mediates the
virtual apoptotic effect.66,67 Administration of CCl4
elevated the caspase 3 in rat liver resulting in liver cell
death (Figure 3). Crocin ameliorated CCl4-induced cell
death as observed in the decreased centrilobullar necrosis
and fatty degenerations in combination group (Figure 1). It
is plausible that antioxidant, radical scavenging effects and
anti-inflammatory actions of crocin, reported in this study,
interfered with CCl4 induced elevation of caspase 3 activity
and hence the liver cells were preserved, liver weight was
normalized and functions were restored, this scenario has
been supported by our collective results as well as previous
results.68e70Conclusion
In conclusion, our findings revealed that crocin has
encouraging protective properties against CCl4-induced
hepatotoxicity. These protective effects attributable to
more than one mechanisms namely: modulation of metab-
olizing enzymes favoring low CCl4 generated free radical
accumulation, free radical scavenging potential, antioxidant
activity, anti-inflammatory effect and inhibition of caspase 3
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